Complementary Basal Insulin Plus Incretin System-Targeted Agents in Complex Patients with Diabetes - The Rationale, Evidence, and Mechanistic Complementarity of Basal Insulin plus Short-Acting GLP-1 RAs in Fixed Combination Regimens for Control of FPG and Postprandial Hyperglycemia (PPG) - Julio Rosenstock, MD

Complementary Basal Insulin Plus Incretin System-Targeted Agents in Complex Patients with Diabetes - The Rationale, Evidence, and Mechanistic Complementarity of Basal Insulin plus Short-Acting GLP-1 RAs in Fixed Combination Regimens for Control of FPG and Postprandial Hyperglycemia (PPG) - Julio Rosenstock, MD


Published

June 27, 2016

Created by

CMEducation Resources symposium